Molecules/BIMEKIZUMAB

BIMEKIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2021

Mechanism of action: Interleukin 17A inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BIMEKIZUMABBIMEKIZUMAB-BKZXBIMZELXUCB-4940UCB4940

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to BIMEKIZUMAB

Loading drug network...